Skip to content
10-Q

Quarterly Report

Mural Oncology plc

0000950170-25-071364

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 1, 2025 17.27M sh
Shares Diluted Q1 2025 · Mar 31, 2025 17.17M sh
Shares Diluted Q1 2025 · Mar 31, 2024 16.79M sh
Capex Q1 2025 · Mar 31, 2025 $10K
Capex Q1 2025 · Mar 31, 2024 $55K
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$36.8M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$37.34M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $106.68M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $115.46M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $107.26M
Stockholders Equity Q1 2025 · Mar 31, 2025 $107.89M
Stockholders Equity Q1 2025 · Dec 31, 2024 $140.5M
Stockholders Equity Q1 2025 · Mar 31, 2024 $234.93M
Stockholders Equity Q1 2025 · Dec 31, 2023 $263.82M
Current Liabilities Q1 2025 · Mar 31, 2025 $23.15M
Current Liabilities Q1 2025 · Dec 31, 2024 $26.2M
Total Liabilities Q1 2025 · Mar 31, 2025 $24.19M
Total Liabilities Q1 2025 · Dec 31, 2024 $28.89M
Current Assets Q1 2025 · Mar 31, 2025 $117.65M
Current Assets Q1 2025 · Dec 31, 2024 $152.92M
Total Assets Q1 2025 · Mar 31, 2025 $132.08M
Total Assets Q1 2025 · Dec 31, 2024 $169.39M
Eps Diluted Q1 2025 · Mar 31, 2025 −$1.93
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.84
Eps Basic Q1 2025 · Mar 31, 2025 −$1.93
Eps Basic Q1 2025 · Mar 31, 2024 −$1.84
Sga Expense Q1 2025 · Mar 31, 2025 $6.96M
Sga Expense Q1 2025 · Mar 31, 2024 $7.17M
Rd Expense Q1 2025 · Mar 31, 2025 $27.43M
Rd Expense Q1 2025 · Mar 31, 2024 $26.87M
Net Income Q1 2025 · Mar 31, 2025 −$33.14M
Net Income Q1 2025 · Mar 31, 2024 −$30.92M
Operating Income Q1 2025 · Mar 31, 2025 −$34.38M
Operating Income Q1 2025 · Mar 31, 2024 −$34.03M